MeiraGTx Holdings plc (NASDAQ:MGTX) CEO Sells $231,878.33 in Stock

MeiraGTx Holdings plc (NASDAQ:MGTX) CEO Alexandria Forbes sold 35,839 shares of the firm’s stock in a transaction on Tuesday, January 7th. The stock was sold at an average price of $6.47, for a total transaction of $231,878.33. Following the completion of the transaction, the chief executive officer now directly owns 1,395,102 shares of the company’s stock, valued at approximately $9,026,309.94. This represents a 2.50 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

MeiraGTx Stock Down 2.4 %

MGTX stock opened at $6.20 on Friday. The company has a debt-to-equity ratio of 0.86, a current ratio of 2.34 and a quick ratio of 2.34. The firm’s fifty day simple moving average is $6.29 and its 200-day simple moving average is $5.14. MeiraGTx Holdings plc has a 12 month low of $3.85 and a 12 month high of $7.37. The company has a market capitalization of $484.55 million, a P/E ratio of -5.12 and a beta of 1.26.

Institutional Investors Weigh In On MeiraGTx

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets boosted its stake in shares of MeiraGTx by 142.5% in the third quarter. BNP Paribas Financial Markets now owns 9,319 shares of the company’s stock worth $39,000 after buying an additional 5,476 shares during the last quarter. China Universal Asset Management Co. Ltd. lifted its holdings in MeiraGTx by 97.0% in the third quarter. China Universal Asset Management Co. Ltd. now owns 14,886 shares of the company’s stock valued at $62,000 after acquiring an additional 7,330 shares during the period. The Manufacturers Life Insurance Company boosted its position in MeiraGTx by 19.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 17,763 shares of the company’s stock worth $75,000 after purchasing an additional 2,839 shares in the last quarter. SG Americas Securities LLC acquired a new stake in shares of MeiraGTx during the 3rd quarter worth approximately $82,000. Finally, Hsbc Holdings PLC increased its holdings in shares of MeiraGTx by 100.9% during the 2nd quarter. Hsbc Holdings PLC now owns 23,954 shares of the company’s stock valued at $102,000 after purchasing an additional 12,029 shares in the last quarter. 67.48% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Royal Bank of Canada upped their target price on MeiraGTx from $9.00 to $11.00 and gave the company an “outperform” rating in a research report on Thursday, November 14th. Chardan Capital restated a “buy” rating and issued a $36.00 price objective on shares of MeiraGTx in a research note on Monday, November 18th.

About MeiraGTx

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.